Transgender Medicine

Discharge Criteria - Feminizing/masculinizing hormone therapy

1. Patient has been on the same hormone regimen for 2 consecutive years with no anticipated future changes required 
2. No further transition-related surgery plans
3. No other active endocrine issue being followed

​​​​​​Resources: 

• Letter to primary care provider - feminizing hormone therapy
• Letter to primary care provider - masculinizing hormone therapy
• Letter to patient - feminizing hormone therapy
• Letter to patient - masculinizing hormone therapy

Topic Expert Review: Raymond Fung, Lisa Alexander  

Primary Care review: Dr Curtis Handford, DFCM, St Michael's Hospital 

Plain language review: Katrina Grieve, St Michael's Hospital 

References:  

1. Wylie C Hembree, Peggy T Cohen-Kettenis, Louis Gooren, Sabine E Hannema, Walter J Meyer, M Hassan Murad, Stephen M Rosenthal, Joshua D Safer, Vin Tangpricha, Guy G T’Sjoen, Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, Volume 102, Issue 11, 1 November 2017, Pages 3869–3903, https://doi.org/10.1210/jc.2017-01658 

2. Bourns A. Guidelines for gender-affirming primary care with trans and non binary patients. Sherbourne Health. https://www.rainbowhealthontario.ca/wp-content/uploads/2021/06/Guidelines-FINAL-4TH-EDITION-c.pdf.